Today: 15 January 2026
Subscribe

GSK Stock News Today (Dec. 23, 2025): Buyback Update, Director Buying, US Drug-Pricing Deal, and FDA Wins — What Analysts Forecast Next

GSK Stock News Today (Dec. 23, 2025): Buyback Update, Director Buying, US Drug-Pricing Deal, and FDA Wins — What Analysts Forecast Next

GSK plc stock is ending 2025 with a dense cluster of catalysts—some bullish, some complicated, and all very “big pharma in an election-year policy blender.” Early Tuesday (Dec. 23, 2025), GSK’s ADR (NYSE: GSK) traded around $48.59, essentially flat on
23 December 2025
····
Anglo American plc Stock (AAL): Dividend Dates, Anglo‑Teck Merger Milestones, and 2026 Copper Forecasts (Dec. 23, 2025)

Anglo American plc Stock (AAL): Dividend Dates, Anglo‑Teck Merger Milestones, and 2026 Copper Forecasts (Dec. 23, 2025)

London-listed Anglo American plc is ending 2025 with its investment story compressed into two big levers: a once-in-a-generation copper market and a once-in-a-generation corporate reshuffle. On December 23, those levers are both moving. The company has published provisional 2026 dividend
23 December 2025
····
Unilever PLC Stock (ULVR, NYSE: UL): Latest News, Forecasts and Analyst Outlook as the Magnum Spin-Off Reshapes the Group (Dec. 23, 2025)

Unilever PLC Stock (ULVR, NYSE: UL): Latest News, Forecasts and Analyst Outlook as the Magnum Spin-Off Reshapes the Group (Dec. 23, 2025)

Unilever PLC stock is heading into year-end with a rare combination of “boring-staples” defensive qualities and very non-boring corporate action. The company has now completed the demerger of its ice cream business into The Magnum Ice Cream Company (TMICC) and
23 December 2025
····
British American Tobacco (BATS) Stock Update: Buyback Nears Its Finish Line, Dividend Date Looms, and 2026 Guidance Turns Cautious

British American Tobacco (BATS) Stock Update: Buyback Nears Its Finish Line, Dividend Date Looms, and 2026 Guidance Turns Cautious

British American Tobacco p.l.c. (BAT) is ending 2025 with a familiar cocktail for investors: steady cash returns, aggressive capital allocation, and a tug-of-war between “smoke-free” growth ambitions and regulatory/competitive reality. On 23 December 2025, the company published a fresh “Transaction
23 December 2025
····
1 … 680 681 682 683 684 … 2,090
Go toTop